课题基金 / 基金详情

NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology

NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology
NIAID- VRC - PREMISE - 通过微生物和免疫监测和流行病学的流行病应对存储库
批准号:
10722411
负责人:
CHRISTOPHER CASE
金额:
$88.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-04 至 2027-09-15

项目摘要

项目成果

CHRISTOPHER CASE的其他基金

相似基金

相关文献

中文摘要
翻译
VRC任务的关键组成部分之一是将有希望的疫苗和候选治疗方法从实验室迅速推进到临床。有必要支持转化研究,以确定治疗和预防传染病的新疗法或方法。通过微生物和生物信息库,pre已经发展成为一个流行病应对库
英文摘要
One of the key components of the VRC mission involves the rapid advancement of promising vaccine and therapeutic candidates from the laboratory to the clinic. There is a need for supporting translational research leading to identification of new therapies or approaches in treating and preventing infectious diseases. PREMISE has been developed as a Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology, and provides detection and surveillance of novel and emerging pathogens and deep analysis of host immune responses at a population-wide scale in order to prepare for an effective response to infectious threats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology
  • 批准号:
    10710451
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2022
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents
  • 批准号:
    10722428
  • 项目类别:
  • 资助金额:
    $219.83万
  • 财政年份:
    2019
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
TUBERCULOSIS VACCINE DEVELOPMENT
  • 批准号:
    9161858
  • 项目类别:
  • 资助金额:
    $200.0万
  • 财政年份:
    2015
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
MALARIA VACCINE EVALUATION
  • 批准号:
    9161854
  • 项目类别:
  • 资助金额:
    $395.18万
  • 财政年份:
    2015
  • 负责人:
    CHRISTOPHER CASE
  • 依托单位:
海外基金